Hosted on MSN16h
Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble
Dexcom stock stock recovered Friday after the diabetes devices maker missed fourth-quarter profit expectations.
DexCom Inc. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
Dexcom, Inc.'s (NASDAQ:DXCM) fourth-quarter revenue rose 8% year-over-year to $1.114 billion, beating the analyst consensus ...
2DXCM : DexCom Unusual Options Activity
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...